Diabetes in Older Adults

Why Diabetes in Older Adults Is a Distinct Clinical Challenge

Diabetes in older adults — generally defined as adults aged 65 and above — is not simply the same disease it is in younger patients with different numbers. The physiological changes of aging, the increasing burden of coexisting conditions, the altered pharmacokinetics of medications, and the specific geriatric syndromes that intersect with diabetes (frailty, cognitive impairment, fall risk, polypharmacy) create a distinct clinical picture that requires individualized, age-appropriate management approaches that standard diabetes guidelines do not fully address. Understanding these special considerations helps older adults with diabetes, their families, and their caregivers navigate the additional complexity of managing this condition at an age when the stakes of both overtreatment (hypoglycemia causing falls and hospitalization) and undertreatment (accelerated complications affecting quality of life and independence) are particularly high. Our guide on what is diabetes provides the foundational overview; this article covers the specific considerations that make diabetes management in older adults different from management at younger ages.

Diabetes in Older Adults: The Numbers Approximately 29% of U.S. adults aged 65 and older have diabetes — nearly 1 in 3 seniors. An additional 48% have prediabetes. By age 80, more than half of Americans have prediabetes or diabetes. Type 2 diabetes is the predominant form in older adults, though older adults can also develop Type 1 diabetes or LADA (Latent Autoimmune Diabetes in Adults). Diabetes is the seventh leading cause of death in the United States and a major driver of disability in the senior population.

Why Diabetes Risk Increases With Age

The dramatically rising prevalence of diabetes with advancing age reflects several age-related physiological changes that increase both insulin resistance and beta cell dysfunction:

Loss of skeletal muscle mass (sarcopenia): Age-related muscle loss reduces the body’s overall capacity for insulin-stimulated glucose disposal, since skeletal muscle is the primary site of post-meal glucose uptake. Adults lose approximately 3–8% of muscle mass per decade after age 30, with the rate accelerating after 60 — and each kilogram of lost muscle substantially reduces glucose disposal capacity. Our guide on age and Type 2 diabetes risk covers these mechanisms in detail.
Increased visceral fat accumulation: Even in older adults who maintain a stable body weight, body composition shifts toward greater visceral fat and less skeletal muscle with advancing age. Since visceral fat directly drives insulin resistance and inflammation, this body composition shift worsens insulin sensitivity independent of changes in body weight or BMI. Our guide on belly fat and diabetes risk covers the relationship between visceral fat and metabolic disease.
Declining beta cell function: Pancreatic beta cell capacity for first-phase insulin secretion (the rapid, early insulin release in response to rising glucose) declines with age, producing higher post-meal glucose peaks than in younger adults eating the same foods. This decline begins in the fourth decade and accelerates with age — meaning that even older adults without diabetes typically have higher post-meal glucose values than younger adults.
Reduced physical activity: Older adults are more likely to be sedentary than younger adults, often due to pain, mobility limitations, or chronic illness — and physical inactivity directly worsens insulin resistance by reducing muscle GLUT4 transporter activity. Our guide on sedentary lifestyle and blood sugar explains the mechanisms.

doctor discussing diabetes treatment plan with an elderly patient including medication review and glucose goals — Older adults with diabetes benefit from comprehensive geriatric assessments that evaluate functional status, fall risk, cognitive function, and medication burden to tailor safe and effective treatment plans.

Individualized Blood Glucose Targets for Older Adults

One of the most important principles in diabetes management for older adults is the recognition that the standard A1C target of below 7.0% — appropriate for most younger and middle-aged adults — is not universally appropriate for older adults, and that applying this target rigidly to elderly patients can cause more harm than benefit through hypoglycemia risk and excessive medication burden. The American Diabetes Association recommends individualized A1C targets for older adults based on a stratified framework:

Healthy older adults (good functional status, no significant cognitive impairment, few comorbidities, reasonable life expectancy): A1C target below 7.0–7.5% — similar to younger adults, as these patients can benefit from tight control with acceptable hypoglycemia risk
Complex or intermediate older adults (multiple chronic illnesses, cognitive impairment, 2+ ADL limitations, or difficulty with self-management): A1C target below 8.0% — a less stringent target that reduces hypoglycemia risk while still limiting the most severe complications
Very complex or poor health older adults (end-stage chronic illness, long-term care residents, moderate to severe dementia, or limited life expectancy): A1C target below 8.5% or no specific A1C target, with management focused on symptom control and safety rather than glucose optimization

The rationale for these tiered targets is that the benefits of tight glycemic control (prevention of microvascular complications) accrue over 5–10 years, while the harms of tight control (hypoglycemia causing falls, fractures, cardiac arrhythmias, cognitive impairment, and death) are immediate. For older adults with limited life expectancy or significant frailty, the risk-benefit balance shifts substantially toward less aggressive control. Our guide on what is normal blood sugar covers the interpretation of glucose values that underpin these targets, and our guide on what the A1C test means explains how A1C relates to average blood glucose in ways that are relevant to treatment goal-setting.

The Hypoglycemia Problem in Older Adults

Hypoglycemia (abnormally low blood glucose) is the most serious immediate medication-related risk in older adults with diabetes, and its consequences in this population are far more severe than in younger adults. In older adults, hypoglycemia causes:

Falls and fall-related injuries — hypoglycemia produces dizziness, confusion, weakness, and impaired coordination that dramatically increase fall risk; a single fall in a frail older adult can result in hip fracture, hospitalization, and a trajectory toward loss of independence
Cardiac arrhythmias — hypoglycemia triggers adrenergic responses (epinephrine release) that can precipitate dangerous cardiac arrhythmias, and older adults with underlying cardiovascular disease are at higher risk of hypoglycemia-associated cardiac events
Accelerated cognitive decline — repeated hypoglycemic episodes are independently associated with increased risk of dementia and cognitive impairment in older adults, and acute severe hypoglycemia can produce focal neurological deficits
Impaired hypoglycemia awareness — many older adults develop hypoglycemia unawareness (failure to feel warning symptoms until glucose falls to dangerous levels) due to blunted adrenergic responses with age, repeated hypoglycemia episodes, and concurrent beta-blocker use

The medications most associated with hypoglycemia risk in older adults are sulfonylureas (particularly glibenclamide/glyburide, which has a long duration of action and should generally be avoided in older adults) and insulin. Metformin, GLP-1 receptor agonists, and SGLT-2 inhibitors carry substantially lower intrinsic hypoglycemia risk and are generally preferred in older adults when medication is needed. Our guides on fatigue and blood sugar problems and what is normal blood sugar provide context for recognizing when symptoms may reflect blood glucose issues.

Medications for Diabetes in Older Adults: What Changes With Age

Medication selection for older adults with diabetes is significantly influenced by the age-related physiological changes that alter drug absorption, distribution, metabolism, and excretion — as well as by the geriatric syndromes (cognitive impairment, falls, polypharmacy) that change the risk-benefit calculation for specific agents. Key medication considerations in older adults with diabetes include:

Metformin: Metformin remains the preferred first-line agent for Type 2 diabetes in older adults who tolerate it, as it does not cause hypoglycemia, produces modest weight loss, has favorable cardiovascular effects, and is inexpensive. However, metformin must be used cautiously or avoided in older adults with reduced kidney function (eGFR below 30 mL/min/1.73m² is a contraindication; below 45 requires dose reduction), as reduced kidney clearance of metformin increases the rare but serious risk of lactic acidosis. Regular kidney function monitoring (at least annually) is essential for older adults on metformin, and the dose should be reviewed whenever kidney function declines.

GLP-1 receptor agonists: Medications such as semaglutide (Ozempic, Rybelsus) and liraglutide (Victoza) provide excellent glucose lowering with minimal hypoglycemia risk, produce cardiovascular benefit in high-risk patients (demonstrated in multiple large outcome trials), and promote weight loss. The main disadvantage in older adults is the gastrointestinal side effects (nausea, vomiting, decreased appetite) that can cause problematic weight loss in already underweight or frail older adults — nutritional monitoring is important when using these agents in the elderly.

SGLT-2 inhibitors: Medications such as empagliflozin (Jardiance) and dapagliflozin (Farxiga) lower glucose by causing the kidneys to excrete excess glucose in the urine, and have demonstrated impressive cardiovascular and kidney-protective benefits in large trials. However, their glucose-lowering effect is reduced in older adults with kidney impairment (and they should not be used when eGFR is below 20–30 depending on the agent), and they carry specific risks in older adults: increased urinary tract and genital infections, volume depletion and orthostatic hypotension (increasing fall risk), and rare risk of diabetic ketoacidosis (which can occur at near-normal glucose levels in older adults with low carbohydrate intake or acute illness — so-called euglycemic DKA).

Sulfonylureas: Sulfonylureas (particularly glyburide/glibenclamide and glipizide) stimulate insulin secretion regardless of glucose level and carry significant hypoglycemia risk. Glyburide has a long half-life and active metabolites that accumulate in kidney impairment — making it particularly dangerous in older adults — and should generally be avoided. Shorter-acting sulfonylureas like glipizide are less problematic but still carry meaningful hypoglycemia risk and require careful monitoring.

Insulin: Many older adults with advanced Type 2 diabetes or Type 1 diabetes require insulin. Key considerations in older adults on insulin include: simplified regimens (basal insulin only is preferred over complex basal-bolus regimens when feasible) to reduce the management burden and injection frequency; less stringent dose targets to reduce hypoglycemia risk; training family members or caregivers in hypoglycemia recognition and treatment; use of insulin pens rather than syringes to reduce dosing errors; and assessment of vision, fine motor function, and cognitive status to ensure the patient can safely self-administer insulin.

Geriatric Syndromes That Intersect With Diabetes in Older Adults

Several geriatric syndromes — conditions that are more common in older adults and result from the interaction of multiple underlying impairments — interact specifically with diabetes and require proactive assessment and management:

Cognitive impairment and dementia: Adults with Type 2 diabetes have approximately 50–65% higher risk of developing Alzheimer’s disease and vascular dementia compared to adults without diabetes — a relationship driven by vascular damage, inflammation, insulin resistance in the brain, and the hypoglycemic episodes that contribute to neuronal injury. Cognitive impairment in turn makes diabetes self-management significantly more difficult: people with dementia may forget to take medications, may not recognize or respond appropriately to hypoglycemia symptoms, may not accurately report symptoms or glucose readings, and require caregiver involvement in all aspects of diabetes management. Our guide on what is insulin resistance covers the brain insulin resistance mechanisms that link metabolic dysfunction to cognitive decline.

Depression: Adults with diabetes have approximately twice the rate of clinically significant depression compared to the general population, and older adults with both diabetes and depression have significantly worse glycemic control, worse medication adherence, higher rates of complications, and higher mortality than those with diabetes alone. Routine screening for depression using validated tools (PHQ-9) is recommended in all older adults with diabetes, and integrated treatment of depression and diabetes produces better outcomes than managing the two conditions in isolation.

Falls and fractures: Adults with diabetes have significantly higher fall rates than those without diabetes — driven by peripheral neuropathy (impaired proprioception and balance), orthostatic hypotension (from autonomic neuropathy and some diabetes medications), hypoglycemia episodes, visual impairment from diabetic retinopathy, and foot problems. Fracture risk is also elevated in people with Type 1 and Type 2 diabetes despite often normal or elevated bone density, because diabetes impairs bone quality through glycation of bone matrix proteins. Fall prevention assessments, physical therapy for balance and gait, and medication review to minimize fall-risk medications are important components of comprehensive diabetes care in older adults.

Frailty: Frailty — characterized by unintentional weight loss, exhaustion, low physical activity, weak grip strength, and slow gait speed — is more common in older adults with diabetes and significantly modifies the risk-benefit calculation for diabetes management intensity. Frail older adults are at particularly high risk for adverse effects of aggressive glucose lowering (hypoglycemia causing falls, hospitalization, acute illness) while having reduced potential to benefit from tight glycemic control (given shorter life expectancy and the long time horizon required to benefit from microvascular complication prevention). Identification of frailty using validated screening tools should influence treatment target selection and medication choices in older adults with diabetes. Our guide on weight gain and insulin resistance provides context on metabolic changes in body composition that affect frailty risk in older adults with diabetes.

Nutrition and Physical Activity in Older Adults With Diabetes

Nutritional management of diabetes in older adults requires balancing the glycemic goals of diabetes management against the nutritional needs of aging — where undernutrition and unintentional weight loss are common and dangerous problems that must not be exacerbated by overly restrictive dietary advice. The same carbohydrate-conscious eating principles that apply to younger adults with diabetes apply here — reducing refined carbohydrates, prioritizing fiber-rich foods, limiting sugary beverages — but with important caveats for the older adult population:

Protein needs are higher in older adults (approximately 1.2–1.5 g/kg/day) to counter age-related muscle loss and maintain functional status; very low-calorie or very low-protein diets that might be appropriate for weight loss in younger obese adults can cause harmful muscle wasting in older adults
Older adults are at higher risk of micronutrient deficiencies (vitamin D, vitamin B12, calcium, magnesium) that are relevant to glucose metabolism and bone health; nutritional assessment should include evaluation of these deficiencies
Practical barriers to healthy eating — fixed incomes limiting food choices, dentition problems limiting food variety, diminished appetite or taste, social isolation reducing meal frequency, and difficulty with food preparation — are common in older adults and must be addressed in any nutritional plan

Physical activity remains one of the most effective interventions for glucose control in older adults with diabetes, but the type and intensity of exercise should be adapted to functional capacity and comorbidities. Resistance training is particularly important in older adults to counter sarcopenia, and balance exercises (tai chi, yoga, balance boards) specifically reduce fall risk — which is a major concern given the fall and fracture risks associated with diabetes in this population. Our guide on sedentary lifestyle and blood sugar covers how reducing inactivity at any age improves blood glucose, and our guide on how to track your blood sugar numbers provides the monitoring framework that helps older adults and their caregivers detect patterns that inform medication and activity adjustments.

Key Principle: Individualization Over Standardization The most important principle in caring for older adults with diabetes is that a one-size-fits-all approach to treatment targets and medication selection will harm some patients. An 80-year-old who is cognitively intact, physically active, and lives independently has very different risk-benefit considerations than an 80-year-old with moderate dementia, history of falls, and multiple comorbidities managed by a caregiver. Asking “what does good diabetes management look like for this specific person given their functional status, life expectancy, and what matters most to them?” — rather than applying standard targets uniformly — is the foundation of high-quality geriatric diabetes care.

Diabetes Complications in Older Adults: What to Watch For

The long-term complications of diabetes — cardiovascular disease, kidney disease, retinopathy, neuropathy, and foot problems — accumulate over years of elevated blood glucose and are highly prevalent in older adults who may have had diabetes for decades before their current age. Annual screening for these complications is standard of care regardless of age, but the clinical priorities shift somewhat in older adults:

Cardiovascular disease is the leading cause of death in older adults with diabetes. Blood pressure control (target below 130/80 mmHg) and lipid management (statin therapy for most older adults with diabetes) are cardiovascular risk reduction priorities that are at least as important as glycemic control in this population. Our guide on what is insulin resistance covers the cardiovascular mechanisms driven by insulin resistance.
Diabetic kidney disease is more prevalent in older adults both because of longer diabetes duration and because kidney function naturally declines with age. The combination of age-related kidney function decline and diabetes-related kidney damage places many older adults at significantly elevated risk of chronic kidney disease progression. Annual urine albumin testing and kidney function monitoring (eGFR) allow early detection and intervention.
Diabetic foot disease is a major cause of hospitalization, amputation, and disability in older adults with diabetes. Annual comprehensive foot examinations — assessing peripheral sensation, pulses, skin integrity, and foot deformities — combined with patient education about footwear and daily foot inspection are essential components of diabetes care in older adults. Any foot wound in an older adult with diabetes should be evaluated urgently, as the combination of impaired sensation, poor circulation, and immune dysfunction makes healing difficult and progression rapid.
Vision problems from diabetic retinopathy require annual dilated retinal examinations. Vision impairment in older adults with diabetes compounds fall risk and makes glucose monitoring and insulin self-administration more difficult — creating a cascade of safety risks that justify early identification and treatment of retinal disease.

Comprehensive screening for all long-term diabetes complications at diagnosis and annually thereafter remains important in older adults — particularly because many complications, detected early, are highly treatable. The decision about how aggressively to manage complications should be made in the context of the individual patient’s overall health, functional status, and personal goals of care. For older adults in excellent health with many years of expected life, aggressive complication prevention and treatment is fully appropriate. For those with severe illness and limited life expectancy, the focus appropriately shifts toward quality of life and symptom control rather than aggressive complication prevention. Our guide on Type 2 diabetes symptoms and diagnosis provides the comprehensive overview of the diagnosis and initial workup that precedes this ongoing complication monitoring.

Social support and care coordination are also critical in older adults with diabetes. Many older adults live alone, have limited mobility, or are cared for by family members or professional caregivers who need education and support to help manage the condition safely. Diabetes care teams that include social workers, pharmacists, and diabetes educators alongside the physician produce better outcomes in older adults than physician-only care, and integration with the patient’s other specialists (cardiologist, nephrologist, geriatrician) ensures that diabetes management is consistent with the broader care plan.

Sources: American Diabetes Association. “Standards of Medical Care in Diabetes: Older Adults.” Diabetes Care 2024. | CDC — National Diabetes Statistics Report 2022. | NIDDK — Managing Diabetes in Older People. | Mayo Clinic — Diabetes Management in Older Adults. | LeRoith D, et al. “Treatment of Diabetes in Older Adults.” Diabetes Care 2019.